Drug Healthcare And Patient Safety

Drug Healthcare And Patient Safety covers a wide range of topics from basic research to clinical practice to policy development. It provides a valuable information exchange platform for healthcare professionals, drug developers, policy makers and patients worldwide. The journal focuses on how scientific research can improve the safety and effectiveness of drug use, reduce medical errors, and optimize patient care.

The journal encourages interdisciplinary research, including but not limited to pharmacoepidemiology, pharmacoeconomics, drug safety monitoring, medical technology evaluation, and the organization and management of health care services. It publishes research that not only contributes to understanding the mechanisms of action of drugs in different populations, but also addresses how to improve the delivery of healthcare services through a systematic approach. The audience is broad, including clinicians, pharmacists, caregivers, public health experts, healthcare administrators, and healthcare policy analysts. The articles published in the journal are rigorously peer-reviewed, ensuring that the research is scientific and practical, and has important implications for improving the quality of healthcare and patient safety.

《药物保健和患者安全》涵盖了从基础研究到临床实践，再到政策制定的广泛议题。它为全球医疗保健专业人员、药品研发者、政策制定者以及患者提供了一个宝贵的信息交流平台。期刊特别关注如何通过科学研究来提高药品使用的安全性和有效性，降低医疗差错，优化患者护理流程。

该期刊鼓励跨学科的研究，包括但不限于药物流行病学、药物经济学、药物安全监测、医疗技术评估、以及医疗保健服务的组织和管理。它发表的研究不仅有助于理解药物在不同人群中的作用机制，还涉及如何通过系统性的方法来改进医疗保健服务的提供。读者群体广泛，包括临床医生、药师、护理人员、公共卫生专家、医疗管理人员以及医疗保健政策分析师。期刊所发表的文章经过严格的同行评审，确保了研究的科学性和实用性，对提高医疗保健质量和患者安全具有重要意义。

该刊已被国际权威数据库SCIE收录，该刊致力于发表经过严格同行评审的高质量原创文章，反映HEALTH CARE SCIENCES & SERVICES领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2026年影响因子为4.3，平均审稿速度为16 Weeks，近四年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。